P3 Health Partners (PIII) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PIII P3 Health Partners

Watchlist

0.213
-0.002-0.93%

Close Nov 22 16:00 ET

0.202
-0.011-4.98%

Post 20:01 ET

34.69MMarket Cap-247P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

P3 Health Partners Analyst Ratings
BenzingaNov 20 12:12 ET · Ratings
P3 Health Partners to Participate in Upcoming Investor Conferences
BusinesswireNov 20 08:00 ET
TD Cowen Maintains P3 Health Partners(PIII.US) With Hold Rating, Maintains Target Price $0.25
Moomoo NewsNov 20 07:33 ET · Ratings
TD Cowen Maintains P3 Health Partners(PIII.US) With Hold Rating, Cuts Target Price to $0.25
Moomoo NewsNov 19 17:31 ET · Ratings
P3 Health Partners Faces Increased Operating Losses and Capital Raise Needs Amid Negative EBITDA Adjustments
TipRanksNov 19 16:35 ET
Analysts Have Lowered Expectations For P3 Health Partners Inc. (NASDAQ:PIII) After Its Latest Results
Yahoo FinanceNov 15 08:03 ET

Comments

Stock_Drift

Oct 25 15:54

After Hours Ticks. 4:52pm

$Pasithea Therapeutics (KTTA.US)$ $Gulf Resources (GURE.US)$ $Sadot (SDOT.US)$ $Edesa Biotech (EDSA.US)$ $Crown Electrokinetics (CRKN.US)$ $P3 Health Partners (PIII.US)$ $MIRA Pharmaceuticals (MIRA.US)$ $Sky Quarry (SKYQ.US)$ $FGI Industries (FGI.US)$ $Check-Cap (CHEK.US)$ $MEI Pharma (MEIP.US)$ $Healthcare Triangle (HCTI.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$

Boxman

Oct 13 10:08

This company is odd

price is so cheap, whats going on here? any thoghts

Trytosaveabit

Aug 29 17:27

Found me a big ole bottom that’s piqued my fancy! Hehehe

$P3 Health Partners (PIII.US)$ And you knows i likes the bottoms! Hehehe. Especially ifn they treat me well. Just thinking outloud here. But this cat has touched 52wk/ATL just today. I do believe ive found my next DCB play! Keepin that SL tight. But some current events help my curiosity to try!

Moomoo AI

Jan 27 08:07

Despite P3 Health Partners' robust revenue growth and promising future, its P/S ratio lags behind industry peers, suggesting investor skepticism about its future growth. The market appears to factor in potential risks and expected revenue volatility.